Agios Pharmaceuticals
AGIO
AGIO
168 hedge funds and large institutions have $1.34B invested in Agios Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 62 increasing their positions, 48 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.26% more ownership
Funds ownership: 105.77% → 108.03% (+2.3%)
8% less capital invested
Capital invested by funds: $1.46B → $1.34B (-$118M)
18% less call options, than puts
Call options by funds: $4.89M | Put options by funds: $5.99M
Holders
168
Holding in Top 10
2
Calls
$4.89M
Puts
$5.99M
Top Buyers
| 1 | +$31.6M | |
| 2 | +$14.7M | |
| 3 | +$14.3M | |
| 4 |
Morgan Stanley
New York
|
+$13.7M |
| 5 |
CP
Caligan Partners
New York
|
+$9.73M |
Top Sellers
| 1 | -$115M | |
| 2 | -$12.4M | |
| 3 | -$4.97M | |
| 4 |
Goldman Sachs
New York
|
-$4.4M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.19M |